Previous studies reported that the rate of HER2 positivity (IHC score 3+ and/or FISH positive) in Japanese GC patients was approximately 10–20 % [5–7], but testing methods and interpretation criteria were not standardized. This evidence concerns the gene ERBB2 and gastric cancer.